Back to Results
First PageMeta Content
Biotechnology / Emerging technologies / Bioethics / Gene therapy / CRISPR / Mary Ann Liebert /  Inc. / Human genome / Biology / Genetics / Molecular biology


New gene editing tools force renewed debate over therapeutic germline alteration
Add to Reading List

Document Date: 2015-05-16 01:13:33


Open Document

File Size: 35,00 KB

Share Result on Facebook

Company

Mary Ann Liebert Inc. / /

Facility

University of Massachusetts Medical School / /

IndustryTerm

gene editing tools / genome editing technology / gene editing technology / /

MedicalCondition

genetic disease / /

Organization

NIH's Recombinant DNA Advisory Committee / University of Massachusetts Medical School / /

Person

Terence R. Flotte / Celia Haidak Professor / /

Position

Editor-in-Chief / Deputy Chancellor / Dean / Professor of Medical Education / Executive / /

Technology

Gene Therapy / CRISPR/Cas9 Technology / CRISPR/Cas9 genome editing technology / Recombinant DNA / CRISPR/Cas9 gene editing technology / human genome / /

URL

www.tcpdf.org / http /

SocialTag